Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4270301, 8 pages
http://dx.doi.org/10.1155/2016/4270301
Review Article

The Adenosinergic System in Diabetic Retinopathy

1Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal
2Institute for Interdisciplinary Research (III), University of Coimbra, 3030-789 Coimbra, Portugal
3CNC.IBILI, University of Coimbra, 3004-504 Coimbra, Portugal
4Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal
5Association for Innovation and Biomedical Research on Light and Image (AIBILI), 3000-548 Coimbra, Portugal
6Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal
7Department of Life Sciences, Faculty of Sciences and Technology, University of Coimbra, 3000-456 Coimbra, Portugal

Received 10 November 2015; Accepted 29 December 2015

Academic Editor: Sarah Zhang

Copyright © 2016 J. Vindeirinho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Simó and C. Hernández, “Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives,” Trends in Endocrinology & Metabolism, vol. 25, no. 1, pp. 23–33, 2014. View at Publisher · View at Google Scholar
  2. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar
  3. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Fong, L. Aiello, T. W. Gardner et al., “Diabetic retinopathy,” Diabetes Care, vol. 26, supplement 1, pp. S99–S102, 2003. View at Google Scholar
  5. D. A. Antonetti, A. J. Barber, S. K. Bronson et al., “Diabetic retinopathy: seeing beyond glucose-induced microvascular disease,” Diabetes, vol. 55, no. 9, pp. 2401–2411, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Barber, “A new view of diabetic retinopathy: a neurodegenerative disease of the eye,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 2, pp. 283–290, 2003. View at Publisher · View at Google Scholar
  7. A. F. Castilho, J. T. Liberal, F. I. Baptista, J. M. Gaspar, A. L. Carvalho, and A. F. Ambrósio, “Elevated glucose concentration changes the content and cellular localization of AMPA receptors in the retina but not in the hippocampus,” Neuroscience, vol. 219, pp. 23–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Santiago, J. M. Gaspar, F. I. Baptista et al., “Diabetes changes the levels of ionotropic glutamate receptors in the rat retina,” Molecular Vision, vol. 15, pp. 1620–1630, 2009. View at Google Scholar · View at Scopus
  9. A. R. Santiago, J. M. Hughes, W. Kamphuis, R. O. Schlingemann, and A. F. Ambrósio, “Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina,” Brain Research, vol. 1198, pp. 153–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Santiago, T. S. Pereira, M. J. Garrido, A. J. Cristóvão, P. F. Santos, and A. F. Ambrósio, “High glucose and diabetes increase the release of [3H]-d-aspartate in retinal cell cultures and in rat retinas,” Neurochemistry International, vol. 48, no. 6-7, pp. 453–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Santiago, S. C. Rosa, P. F. Santos, A. J. Cristóvão, A. J. Barber, and A. F. Ambrósio, “Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells,” Investigative Ophthalmology and Visual Science, vol. 47, no. 9, pp. 4130–4137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Barber, E. Lieth, S. A. Khin, D. A. Antonetti, A. G. Buchanan, and T. W. Gardner, “Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin,” The Journal of Clinical Investigation, vol. 102, no. 4, pp. 783–791, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. E. C. Leal, C. A. Aveleira, Á. F. Castilho et al., “High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway,” Experimental Eye Research, vol. 88, no. 5, pp. 983–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-H. Park, J.-W. Park, S.-J. Park et al., “Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina,” Diabetologia, vol. 46, no. 9, pp. 1260–1268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Santiago, A. J. Cristóvão, P. F. Santos, C. M. Carvalho, and A. F. Ambrósio, “High glucose induces caspase-independent cell death in retinal neural cells,” Neurobiology of Disease, vol. 25, no. 3, pp. 464–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Aveleira, Á. Castilho, F. Baptista et al., “High glucose and interleukin-1β downregulate interleukin-1 type I receptor (IL-1RI) in retinal endothelial cells by enhancing its degradation by a lysosome-dependent mechanism,” Cytokine, vol. 49, no. 3, pp. 279–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Aveleira, C.-M. Lin, S. F. Abcouwer, A. F. Ambrósio, and D. A. Antonetti, “TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability,” Diabetes, vol. 59, no. 11, pp. 2872–2882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Costa, T. Pereira, A. M. Neto, A. J. Cristóvão, A. F. Ambrósio, and P. F. Santos, “High glucose changes extracellular adenosine triphosphate levels in rat retinal cultures,” Journal of Neuroscience Research, vol. 87, no. 6, pp. 1375–1380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. N. Costa, J. Vindeirinho, C. Cavadas, A. F. Ambrósio, and P. F. Santos, “Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose,” Molecular and Cellular Neuroscience, vol. 50, no. 1, pp. 113–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Kowluru, R. L. Engerman, G. L. Case, and T. S. Kern, “Retinal glutamate in diabetes and effect of antioxidants,” Neurochemistry International, vol. 38, no. 5, pp. 385–390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Kusari, S. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil, “Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats,” Investigative Ophthalmology & Visual Science, vol. 48, no. 11, pp. 5152–5159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Abu El-Asrar, G. Mohammad, G. De Hertogh et al., “Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy,” PLoS ONE, vol. 8, no. 6, Article ID e65472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Krabbe, A. R. Nielsen, R. Krogh-Madsen et al., “Brain-derived neurotrophic factor (BDNF) and type 2 diabetes,” Diabetologia, vol. 50, no. 2, pp. 431–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Liu, L. Tao, X. Fu, Y. Zhao, and X. Xu, “BDNF protects retinal neurons from hyperglycemia through the TrkB/ERK/MAPK pathway,” Molecular Medicine Reports, vol. 7, no. 6, pp. 1773–1778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. B. A. Mysona, M. M. H. Al-Gayyar, S. Matragoon et al., “Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats,” Diabetologia, vol. 56, no. 10, pp. 2329–2339, 2013. View at Publisher · View at Google Scholar
  26. J. K. Krady, A. Basu, C. M. Allen et al., “Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy,” Diabetes, vol. 54, no. 5, pp. 1559–1565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Miyamoto, S. Khosrof, S.-E. Bursell et al., “Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10836–10841, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. A. P. Adamis and A. J. Berman, “Immunological mechanisms in the pathogenesis of diabetic retinopathy,” Seminars in Immunopathology, vol. 30, no. 2, pp. 65–84, 2008. View at Publisher · View at Google Scholar
  29. A. Crooke, A. Guzmán-Aranguez, A. Peral, M. K. A. Abdurrahman, and J. Pintor, “Nucleotides in ocular secretions: their role in ocular physiology,” Pharmacology and Therapeutics, vol. 119, no. 1, pp. 55–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. W. Gardner, D. A. Antonetti, A. J. Barber, K. F. LaNoue, and S. W. Levison, “Diabetic retinopathy: more than meets the eye,” Survey of Ophthalmology, vol. 47, supplement 2, pp. S253–S262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. T. V. Dunwiddie and S. A. Masino, “The role and regulation of adenosine in the central nervous system,” Annual Review of Neuroscience, vol. 24, pp. 31–55, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Sebastião and J. A. Ribeiro, “Adenosine receptors and the central nervous system,” in Adenosine Receptors in Health and Disease, vol. 193 of Handbook of Experimental Pharmacology, pp. 471–534, Springer, Berlin, Germany, 2009. View at Publisher · View at Google Scholar
  33. J. Wardas, “Neuroprotective role of adenosine in the CNS,” Polish Journal of Pharmacology, vol. 54, no. 4, pp. 313–326, 2002. View at Google Scholar · View at Scopus
  34. M. Matos, E. Augusto, P. Agostinho, R. A. Cunha, and J.-F. Chen, “Antagonistic interaction between adenosine A2A Receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes,” Journal of Neuroscience, vol. 33, no. 47, pp. 18492–18502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. X.-L. Liu Xiao-Ling, R. Zhou, Q.-Q. Pan et al., “Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina,” Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6625–6632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Wurm, I. Iandiev, M. Hollborn et al., “Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina,” Experimental Eye Research, vol. 87, no. 4, pp. 385–393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. R. Santiago, F. I. Baptista, P. F. Santos et al., “Role of microglia adenosine A2A receptors in retinal and brain neurodegenerative diseases,” Mediators of Inflammation, vol. 2014, Article ID 465694, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Haskó, J. Linden, B. Cronstein, and P. Pacher, “Adenosine receptors: therapeutic aspects for inflammatory and immune diseases,” Nature Reviews Drug Discovery, vol. 7, no. 9, pp. 759–770, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Ralevic and G. Burnstock, “Receptors for purines and pyrimidines,” Pharmacological Reviews, vol. 50, no. 3, pp. 413–492, 1998. View at Google Scholar · View at Scopus
  40. G. D. Housley, A. Bringmann, and A. Reichenbach, “Purinergic signaling in special senses,” Trends in Neurosciences, vol. 32, no. 3, pp. 128–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. P.-C. Huang, Y.-T. Hsiao, S.-Y. Kao et al., “Adenosine A2A receptor up-regulates retinal wave frequency via starburst amacrine cells in the developing rat retina,” PLoS ONE, vol. 9, no. 4, Article ID e95090, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Li, Z. Zhang, M. R. Blackburn, S. W. Wang, C. P. Ribelayga, and J. O'Brien, “Adenosine and dopamine receptors coregulate photoreceptor coupling via gap junction phosphorylation in mouse retina,” Journal of Neuroscience, vol. 33, no. 7, pp. 3135–3150, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Wurm, T. Pannicke, I. Iandiev et al., “Purinergic signaling involved in Müller cell function in the mammalian retina,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 324–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. P. J. Gebicke-Haerter, F. Christoffel, J. Timmer, H. Northoff, M. Berger, and D. Van Calker, “Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation,” Neurochemistry International, vol. 29, no. 1, pp. 37–42, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Hammarberg, G. Schulte, and B. B. Fredholm, “Evidence for functional adenosine A3 receptors in microglia cells,” Journal of Neurochemistry, vol. 86, no. 4, pp. 1051–1054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Haskó, P. Pacher, E. S. Vizi, and P. Illes, “Adenosine receptor signaling in the brain immune system,” Trends in Pharmacological Sciences, vol. 26, no. 10, pp. 511–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Koscsó, B. Csóka, Z. Selmeczy et al., “Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process,” The Journal of Immunology, vol. 188, no. 1, pp. 445–453, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. B. Grant, R. W. Tarnuzzer, S. Caballero et al., “Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells,” Circulation Research, vol. 85, no. 8, pp. 699–706, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. G. A. Lutty and D. S. McLeod, “Retinal vascular development and oxygen-induced retinopathy: a role for adenosine,” Progress in Retinal and Eye Research, vol. 22, no. 1, pp. 95–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Kvanta, S. Seregard, S. Sejersen, B. Kull, and B. B. Fredholm, “Localization of adenosine receptor messenger RNAs in the rat eye,” Experimental Eye Research, vol. 65, no. 5, pp. 595–602, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. W.-J. Wan, D.-M. Cui, X. Yang et al., “Expression of adenosine receptors in human retinal pigment epithelium cells in vitro,” Chinese Medical Journal, vol. 124, no. 8, pp. 1139–1144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. L. M. Kreckler, T. C. Wan, Z.-D. Ge, and J. A. Auchampach, “Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 1, pp. 172–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Gessi, S. Merighi, K. Varani, E. Leung, S. Mac Lennan, and P. A. Borea, “The A3 adenosine receptor: an enigmatic player in cell biology,” Pharmacology and Therapeutics, vol. 117, no. 1, pp. 123–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. R. Elliott, F. B. Chekeni, P. C. Trampont et al., “Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance,” Nature, vol. 461, no. 7261, pp. 282–286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Latini and F. Pedata, “Adenosine in the central nervous system: release mechanisms and extracellular concentrations,” Journal of Neurochemistry, vol. 79, no. 3, pp. 463–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. I. Iandiev, A. Wurm, T. Pannicke et al., “Ectonucleotidases in Müller glial cells of the rodent retina: involvement in inhibition of osmotic cell swelling,” Purinergic Signalling, vol. 3, no. 4, pp. 423–433, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Ricatti, L. D. Alfie, É. G. Lavoie, J. Sévigny, P. J. Schwarzbaum, and M. P. Faillace, “Immunocytochemical localization of NTPDases1 and 2 in the neural retina of mouse and zebrafish,” Synapse, vol. 63, no. 4, pp. 291–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. J.-S. Choi and A. J. Berdis, “Nucleoside transporters: biological insights and therapeutic applications,” Future Medicinal Chemistry, vol. 4, no. 11, pp. 1461–1478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Nagase, M. Tomi, M. Tachikawa, and K.-I. Hosoya, “Functional and molecular characterization of adenosine transport at the rat inner blood-retinal barrier,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1758, no. 1, pp. 13–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. S.-I. Akanuma, T. Soutome, E. Hisada, M. Tachikawa, Y. Kubo, and K.-I. Hosoya, “Na+-independent nucleoside transporters regulate adenosine and hypoxanthine levels in Müller cells and the inner blood–retinal barrier,” Investigative Ophthalmology and Visual Science, vol. 54, no. 2, pp. 1469–1477, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. F. E. Parkinson, V. L. Damaraju, K. Graham et al., “Molecular biology of nucleoside transporters and their distributions and functions in the brain,” Current Topics in Medicinal Chemistry, vol. 11, no. 8, pp. 948–972, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. B. P. Klyuch, N. Dale, and M. J. Wall, “Deletion of ecto-5′-nucleotidase (CD73) reveals direct action potential-dependent adenosine release,” Journal of Neuroscience, vol. 32, no. 11, pp. 3842–3847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Vindeirinho, G. N. Costa, M. B. Correia, C. Cavadas, and P. F. Santos, “Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system,” PLoS ONE, vol. 8, no. 6, Article ID e67499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. B. B. Fredholm, “Adenosine, an endogenous distress signal, modulates tissue damage and repair,” Cell Death and Differentiation, vol. 14, no. 7, pp. 1315–1323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. J. M. N. Duarte, C. R. Oliveira, A. F. Ambrósio, and R. A. Cunha, “Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats,” Neurochemistry International, vol. 48, no. 2, pp. 144–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Grden, M. Podgorska, A. Szutowicz, and T. Pawelczyk, “Diabetes-induced alterations of adenosine receptors expression level in rat liver,” Experimental and Molecular Pathology, vol. 83, no. 3, pp. 392–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Grdeń, M. Podgórska, A. Szutowicz, and T. Pawełczyk, “Altered expression of adenosine receptors in heart of diabetic rat,” Journal of Physiology and Pharmacology, vol. 56, no. 4, pp. 587–597, 2005. View at Google Scholar · View at Scopus
  68. T. Pawelczyk, M. Grden, R. Rzepko, M. Sakowicz, and A. Szutowicz, “Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat,” American Journal of Pathology, vol. 167, no. 2, pp. 315–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. J. C. M. Lau, R. A. Kroes, J. R. Moskal, and R. A. Linsenmeier, “Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina,” Molecular Vision, vol. 19, pp. 1538–1553, 2013. View at Google Scholar
  70. N. M. Elsherbiny, S. Ahmad, M. Naime et al., “ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy,” Life Sciences, vol. 93, no. 2-3, pp. 78–88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. N. M. Elsherbiny, M. Naime, S. Ahmad et al., “Potential roles of adenosine deaminase-2 in diabetic retinopathy,” Biochemical and Biophysical Research Communications, vol. 436, no. 3, pp. 355–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Kocbuch, M. Sakowicz-Burkiewicz, M. Grden, A. Szutowicz, and T. Pawelczyk, “Effect of insulin and glucose on adenosine metabolizing enzymes in human B lymphocytes,” Acta Biochimica Polonica, vol. 56, no. 3, pp. 439–446, 2009. View at Google Scholar · View at Scopus
  73. J.-G. Lee, D. G. Kang, J. R. Yu et al., “Changes in adenosine deaminase activity in patients with type 2 diabetes mellitus and effect of DPP-4 inhibitor treatment on ADA activity,” Diabetes and Metabolism Journal, vol. 35, no. 2, pp. 149–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. G. I. L. Lunkes, D. S. Lunkes, V. M. Morsch et al., “NTPDase and 5′-nucleotidase activities in rats with alloxan-induced diabetes,” Diabetes Research and Clinical Practice, vol. 65, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Pawelczyk, M. Sakowicz, M. Szczepanska-Konkel, and S. Angielski, “Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats,” Archives of Biochemistry and Biophysics, vol. 375, no. 1, pp. 1–6, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Schmatz, M. R. C. Schetinger, R. M. Spanevello et al., “Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats,” Life Sciences, vol. 84, no. 11-12, pp. 345–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Xia, Z. Wang, and F. Zhang, “Association between related purine metabolites and diabetic retinopathy in type 2 diabetic patients,” International Journal of Endocrinology, vol. 2014, Article ID 651050, 9 pages, 2014. View at Publisher · View at Google Scholar
  78. A. S. Ibrahim, M. M. El-shishtawy, W. Zhang, R. B. Caldwell, and G. I. Liou, “A2A adenosine receptor (A2AAR) as a therapeutic target in diabetic retinopathy,” The American Journal of Pathology, vol. 178, no. 5, pp. 2136–2145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. K. E. Trueblood, S. Mohr, and G. R. Dubyak, “Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1,” The American Journal of Physiology—Cell Physiology, vol. 301, no. 5, pp. C1213–C1223, 2011. View at Publisher · View at Google Scholar · View at Scopus